eba-175 rii-ng malaria vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00347555)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium vivaxImmunity, active
Plasmodium vivax immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- eba-175 rii-ng malaria vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01026246 | Phase 1 | Jun 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00347555 | Phase 1 | May 1, 2006 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2006 |
1 organizations
Page 1 / 1